SpringWorks Therapeutics
SWTX
SWTX was delisted on the 30th of June, 2025.
143 hedge funds and large institutions have $1.36B invested in SpringWorks Therapeutics in 2022 Q2 according to their latest regulatory filings, with 31 funds opening new positions, 62 increasing their positions, 35 reducing their positions, and 23 closing their positions.
77% more repeat investments, than reductions
Existing positions increased: 62 | Existing positions reduced: 35
35% more first-time investments, than exits
New positions opened: 31 | Existing positions closed: 23
11.6% more ownership
Funds ownership: 100.27% → 111.87% (+12%)
4% more funds holding
Funds holding: 137 → 143 (+6)
30% less call options, than puts
Call options by funds: $1.32M | Put options by funds: $1.87M
43% less funds holding in top 10
Funds holding in top 10: 7 → 4 (-3)
51% less capital invested
Capital invested by funds: $2.79B → $1.36B (-$1.43B)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
State Street
Boston,
Massachusetts
|
+$83.9M |
| 2 |
ACH
ArrowMark Colorado Holdings
Denver,
Colorado
|
+$71.6M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
+$49.9M |
| 4 |
Nomura Holdings
Tokyo,
Japan
|
+$18.5M |
| 5 |
PF
Phoenix Financial
Givatayim,
Israel
|
+$18.4M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Adage Capital Partners
Boston,
Massachusetts
|
-$47.6M |
| 2 |
Marshall Wace
London,
United Kingdom
|
-$39.8M |
| 3 |
Loomis, Sayles & Company
Boston,
Massachusetts
|
-$30M |
| 4 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
-$24.7M |
| 5 |
PA
Perceptive Advisors
New York
|
-$24.2M |
SWTX Hedge Fund Activity: Q2 2022 in Review
143 of the 5,959 institutional investors tracked by Wall St. Rank reported a position in SpringWorks Therapeutics (SWTX) for Q2 2022, worth a combined $1.36B — down 51% from $2.79B a quarter earlier.
Buyers outnumbered sellers: 31 funds opened new SWTX positions and 23 closed out — a net gain of 8 holders — while 62 added to existing stakes and 35 trimmed.
The largest buyer was State Street, adding an estimated $83.9M. The largest seller was Adage Capital Partners, cutting an estimated $47.6M.
- 143 institutional investors held SpringWorks Therapeutics (SWTX) as of Q2 2022, up from 137 in Q1 2022.
- Funds reported $1.36B of SpringWorks Therapeutics stock for Q2 2022, down 51% quarter-over-quarter.
- 31 funds opened new SpringWorks Therapeutics positions in Q2 2022 and 23 closed out, a net change of +8 holders.
- The largest SpringWorks Therapeutics buyer in Q2 2022 was State Street, an estimated $83.9M added.
- The largest SpringWorks Therapeutics seller in Q2 2022 was Adage Capital Partners, an estimated $47.6M sold.
Based on aggregated 13F filings for Q2 2022.